BioSpace News Archive

Pharm Country

FDA Hits Verrica With Third CRL For Lead Drug Candidate VP-102

In the third and most recent FDA letter, Verrica noted that none of the issues were specific to VP-102 and how it is manufactured.

May 25, 2022
·
2 min read
·
Vanessa Doctor, RN
Drug Development

Money on the Move: Biotechs Target Cancers, Dermatology and Strokes

Private investors, governmental institutions and longtime life sciences investors provided funding to develop therapies for cancers, dermatological problems and acute ischemic strokes.

May 25, 2022
·
4 min read
·
Hannah Chudleigh
Policy

Concerns Mount Over COVID-19 ‘Rebounds’ After Treatment With Pfizer’s Paxlovid

Concerns are mounting for people that have been given Pfizer’s Paxlovid treatment regimen after contracting COVID-19, only to become positive for the infection once again.

May 25, 2022
·
2 min read
·
Jazmine Colatriano
Chemspace Reopens Kyiv Office to Supply Chemicals to Life Sciences Industry

Three months after the invasion began, Yurii Moroz, the executive director of Kyiv-based Chemspace LLC, has returned to his offices to restart operations.

May 25, 2022
·
2 min read
·
Alex Keown
Drug Development

Global Roundup: Iceland’s Alvotech Hits Mark with Biosimilar to Janssen’s Stelara

Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

May 25, 2022
·
7 min read
·
Alex Keown
Job Trends

$2.1B Eli Lilly Expansion to Add 500 New Jobs in Indiana

When the two new sites are up and running, Eli Lilly predicted the project will create up to 500 new jobs - with the expectation of four indirect jobs for each full-time position, based on industry data.

May 25, 2022
·
2 min read
·
Alex Keown
Business

Two Remarkable Women of Takeda’s C-Suite Make the Professional Personal

At the start of Takeda’s fiscal year on April 1, Ramona Sequeira and Julie Kim stepped into new positions on the company’s executive leadership team and became role models for women.

May 25, 2022
·
9 min read
·
Abbey Glasure
Drug Development

Invectys is Pioneering HLA-G Immune Checkpoint Inhibitors in Cancer Therapeutics

Invectys is one of only a few companies investigating HLA-G, a natural immune checkpoint inhibitor, for solid tumors.

May 25, 2022
·
4 min read
·
Gail Dutton
Gamma Knife Market Is Projected to Reach a Market Value of US$ 507.0 Million By 2031 - Comprehensive Research Report By FMI

DUBAI, United Arab Emirates, This Future Market Insights report examines the ‘Global Gamma Knife’ market for the period 2012-2025.

May 25, 2022
·
5 min read
Biobanks Market Demand and Global Competitive Insights 2031

Albany NY, United States: The global biobanks market is expected to witness strong growth during the forecast period between 2021 and 2031.

May 25, 2022
·
5 min read